Company intelligence / Profile preview

Theodorus Funds

Brussels, Belgium

Ownership: Private
Development stage: Other

Overview

Theodorus Funds is a venture capital firm specializing in seed and early-stage investments in biotech, MedTech, life sciences, and deep tech. It has managed over €150M across multiple funds (Theodorus I-IV), invested in 50+ companies, and achieved 28+ exits, including notable ones like MaSTherCell and Ogeda. The firm's team is also involved in the launch of Seido Capital, which focuses on North American life sciences.

Industry: Investors

Beyond the preview

Go deeper on Theodorus Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theodorus Funds.

Explore the full profile